project id: TCGA-PRAD; case submitter id: TCGA-ZG-A9L1; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.65; rna integrity number: 8.0; age at index: 66; days to birth: -24214; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1944; age at diagnosis: 24214; ajcc clinical m: M0; ajcc clinical t: T1c; ajcc pathologic n: N1; ajcc pathologic t: T3b; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1302.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 4; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 5; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1246; initial weight: 750.0; sample id: 95115646-d495-40a4-9770-6700778e4ca9; sample submitter id: TCGA-ZG-A9L1-01A; portion id: dcdce2c8-5bcc-40e6-a33a-27ff956f7557; portion submitter id: TCGA-ZG-A9L1-01A-11; slide id: 86d636e3-1834-4073-a01e-1e92163fd9be; slide submitter id: TCGA-ZG-A9L1-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 50.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; section location: TOP;